NM_004360.5(CDH1):c.48+5C>T AND CDH1-related diffuse gastric and lobular breast cancer syndrome

Germline classification:
Likely benign (1 submission)
Last evaluated:
Aug 18, 2023
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003328433.2

Allele description [Variation Report for NM_004360.5(CDH1):c.48+5C>T]

NM_004360.5(CDH1):c.48+5C>T

Gene:
CDH1:cadherin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q22.1
Genomic location:
Preferred name:
NM_004360.5(CDH1):c.48+5C>T
HGVS:
  • NC_000016.10:g.68737468C>T
  • NG_008021.1:g.5177C>T
  • NM_001317184.2:c.48+5C>T
  • NM_001317185.2:c.-1568+5C>T
  • NM_001317186.2:c.-1772+5C>T
  • NM_004360.4(CDH1):c.48+5C>T
  • NM_004360.5:c.48+5C>TMANE SELECT
  • LRG_301t1:c.48+5C>T
  • LRG_301:g.5177C>T
  • NC_000016.9:g.68771371C>T
  • NM_004360.3:c.48+5C>T
  • NM_004360.4(CDH1):c.48+5C>T
  • NM_004360.4:c.48+5C>T
Links:
dbSNP: rs77312180
NCBI 1000 Genomes Browser:
rs77312180
Molecular consequence:
  • NM_001317184.2:c.48+5C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001317185.2:c.-1568+5C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001317186.2:c.-1772+5C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_004360.5:c.48+5C>T - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
CDH1-related diffuse gastric and lobular breast cancer syndrome
Synonyms:
CDH1-related diffuse gastric and lobular breast cancer
Identifiers:
MONDO: MONDO:0100488; MedGen: CN311521

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001142237ClinGen CDH1 Variant Curation Expert Panel
reviewed by expert panel

(ClinGen CDH1 ACMG Specifications V3.1)		Likely benign
(Aug 18, 2023) 		germlinecuration

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen CDH1 Variant Curation Expert Panel, SCV001142237.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.48+5C>T variant was observed in at least 3 families without a personal and/or family history of diffuse gastric cancer, lobular breast cancer or a signet ring cell tumor (BP2_Supporting; internal data). There are at least 3 in silico predictors in agreement that this variant does not affect splicing (BP4). Therefore, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BS2_Supporting, BP4.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024